Reader
$5 a month
Helps pay for the reporting, editing and production behind Onco'Zine and ADC Review.
- Supports our written coverage
Every week, oncologists, researchers, patients and advocates ask us the same thing: what does this new data actually mean? Onco'Zine and ADC Review exist to answer that clearly and carefully. Your support pays for the work that makes that possible.
Give every month, or give once. Either way, thank you.
$5 a month
Helps pay for the reporting, editing and production behind Onco'Zine and ADC Review.
$15 a month
Everything in Reader, and more of the work beyond the written page.
$30 a month
Everything in Supporter, for those who want to do more.
A single contribution, with no repeat charge. If you pick your own amount, you'll enter it on the next page.
Your payment goes to Sunvalley Communication, LLC, the publisher of Onco'Zine and ADC Review, and is processed securely by Stripe. It is a payment in support of our publications, not a charitable donation, and is not tax-deductible.
Monthly supporters can cancel at any time. Support does not influence what we report or how we report it.
Four things we make, all of them focused on cancer research and care.
Clinical oncology articles and news, written to be read by people who need the detail.
Coverage dedicated to antibody-drug conjugates and the science around them.
Our podcast, where we talk through the developments that matter.
Our video program on how cancer care is changing.
Our podcast and our two directories each have their own way to join in.
Listeners of The Onco'Zine Brief can support the show directly as Patreon members.
Support on PatreonA companion to Onco'Zine and The Onco'Zine Brief. Practices, experts, and businesses involved in cancer research, diagnostics, and care can share their expertise by publishing articles, videos, events, and more.
Membership options and pricing are on the directory's own site.
Visit The Oncology DirectoryBrought to you by ADC Review. It connects businesses and professionals working on the research, development, and manufacture of antibody-drug conjugates. Members can share reviews, articles, videos, events, products, and career opportunities.
Membership options and pricing are on the directory's own site.
Visit the ADC DirectoryIn oncology, the details matter. So we take the time to get them right.
We follow the science from the conference floor to the clinic: new antibody-drug conjugates, evolving standards of care, and the people behind the trials.
We want this coverage to stay independent, and that takes resources: reporting, editing, production, and the time to do it properly.
If Onco'Zine or ADC Review has ever helped you understand a study, prepare for a patient conversation, or keep pace with a fast-moving field, please consider supporting us. Thank you for reading, and for helping us keep telling the story.